BioNTech SE and the Norwegian-based Coalition for Epidemic Preparedness Innovations, or CEPI, said Monday they are partnering to advance an mRNA-based Mpox...
BioNTech SE BNTX, -0.66% and the Norwegian-based Coalition for Epidemic Preparedness Innovations, or CEPI, said Monday they are partnering to advance an mRNA-based Mpox vaccine. BioNTech will start a Phase 1/2 clinical trial of the vaccine called BNT166, while CEPI will commit funding if up to $90 million for the program.
Mpox, which was formerly called monekypox, is a zoonotic infectious disease caused by the monkeypox virus, which causes symptoms including skin rash and mucosal lesions, fever, swollen lymph nodes, head-/muscle ache and sore throat.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Russian troops withdraw from Norway border in drop since start of Ukraine war: officialNorwegian chief of defense said Saturday that '20% or less' of Russian soldiers remain at its border in the Artic compared to when the war in Ukraine started.
Leer más »
Florida schools' Bible-based curriculum under fire from parentsA group of parents in the Sunshine State have expressed concerns, saying schools are trying to indoctrinate their kids with conservative Christianity.
Leer más »